You are here: All Products  > Akeso Completes Enrollment in Phase III Trial of PD-1/VEGF Bi-specific

Akeso Completes Enrollment in Phase III Trial of PD-1/VEGF Bi-specific

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.